BridgeBio Pharma Market Cap

BridgeBio Pharma has a market cap or net worth of $12.55 billion as of March 6, 2026. Its market cap has increased by 83.02% in one year.

Market Cap

12.55B

Enterprise Value

14.10B

1-Year Change

83.02%

Ranking

#803

Market Cap Chart

Since June 27, 2019, BridgeBio Pharma's market cap has increased from $3.32B to $12.55B, an increase of 278.12%. That is a compound annual growth rate of 21.98%.

Market Cap History

Date	Market Cap	% Change
Mar 5, 2026	12.83B	-12.97%
Dec 31, 2025	14.74B	184.24%
Dec 31, 2024	5.19B	-26.16%
Dec 29, 2023	7.02B	516.56%
Dec 30, 2022	1.14B	-53.61%
Dec 31, 2021	2.46B	-71.83%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Genmab	16.89B
Ascendis Pharma	14.57B
Ionis Pharmaceuticals	12.42B
BioMarin Pharmaceutical	11.65B
Summit Therapeutics	11.58B
Jazz Pharmaceuticals	11.30B
Exelixis	10.72B
Madrigal Pharmaceuticals	10.08B

Market Cap Rankings